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Thyroid Lobectomy vs Total Thyroidectomy for Low Risk Papillary Thyroid Cancer: A Systematic 
Review 
Susana Vargas-Pinto, MD, Minerva A Romero Arenas, MD, MPH  
State University of New York at Buffalo, Buffalo, NY; The University of Texas Rio Grande Valley, 
Harlingen, TX 
INTRODUCTION: The 2015 American Thyroid Association (ATA) guidelines called for consideration of 
thyroid lobectomy as an acceptable surgical treatment for small and less aggressive papillary thyroid 
cancers (PTC) with no clinical evidence of metastasis or extrathyroidal extension. Extent of surgery 
however, remains controversial. 
METHODS: A systematic literature review was performed on Pubmed, EMBASE, Scopus and Cochrane 
Library databases using a combination of the keywords: papillary thyroid carcinoma, lobectomy, 
completion thyroidectomy and guidelines during the years 2012 to 2017. Eight retrospective studies 
comparing lobectomy to total thyroidectomy on 1,294 patients with low risk PTC were included for 
analysis. Studies were grouped according to the major themes: survival and completion thyroidectomy. 
RESULTS: Compared to lobectomy, total thyroidectomy does not confer a survival advantage in low risk 
PTC. Despite appropriate preoperative risk stratification approximately 30% of thyroid lobectomy 
candidates will require completion thyroidectomy. 
CONCLUSIONS: The 2015 ATA guidelines encourage personalization of care for patients with low risk 
PTC including a more conservative approach to initial extent of surgery and administration of radioactive 
iodine. A significant proportion of patients treated with lobectomy may require completion procedures 
for loco regional disease control, but which may not pose a negative impact in overall survival. Risks and 
benefits should be discussed carefully with patients. Future research considering outcomes such as 
complication rates, recurrence free survival, need for completion thyroidectomy, and long-term follow-
up is warranted. 
 
